BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33063945)

  • 1. Clinical outcomes of non-osteogenic, non-Ewing soft-tissue sarcoma of bone--experience of the Toronto Sarcoma Program.
    Veitch ZW; Fasih S; Griffin AM; Al-Ezzi EM; Gupta AA; Ferguson PC; Wunder JS; Abdul Razak AR
    Cancer Med; 2020 Dec; 9(24):9282-9292. PubMed ID: 33063945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
    Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
    Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
    Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
    Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
    Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
    Palmerini E; Reichardt P; Hall KS; Bertulli R; Bielack SS; Comandone A; Egerer G; Hansmeier A; Kevric M; Carretta E; Hansson L; Jebsen N; Eriksson M; Bruland ØS; Donati DM; Ibrahim T; Smeland S; Ferrari S
    Cancer; 2023 Nov; 129(22):3564-3573. PubMed ID: 37530385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
    Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
    J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
    Malik AT; Baek J; Alexander JH; Voskuil RT; Khan SN; Scharschmidt TJ
    J Surg Oncol; 2020 Jun; 121(7):1097-1103. PubMed ID: 32133661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and survival of malignant fibrous histiocytoma of the bone: A population-based study using the SEER database.
    Liu B; Wei H; Ren YJ; Zou D; Zhang K; Ma Q; Xiao X
    PLoS One; 2020; 15(6):e0232466. PubMed ID: 32492019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
    Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
    BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
    Livingston JA; Hess KR; Naing A; Hong DS; Patel S; Benjamin RS; Ludwig JA; Conley A; Herzog CE; Anderson P; Meric-Bernstam F; Kurzrock R; Subbiah V
    Oncotarget; 2016 Sep; 7(39):64421-64430. PubMed ID: 27486883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
    Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
    Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional survival of pediatric, adolescent, and young adult soft tissue sarcoma and bone tumor patients.
    Ou JY; Spraker-Perlman H; Dietz AC; Smits-Seemann RR; Kaul S; Kirchhoff AC
    Cancer Epidemiol; 2017 Oct; 50(Pt A):150-157. PubMed ID: 28992567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
    Dineen SP; Roland CL; Feig R; May C; Zhou S; Demicco E; Sannaa GA; Ingram D; Wang WL; Ravi V; Guadagnolo A; Lev D; Pollock RE; Hunt K; Cormier J; Lazar A; Feig B; Torres KE
    Ann Surg Oncol; 2015 Nov; 22(12):3913-20. PubMed ID: 25743327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.
    Romeo S; Bovée JV; Kroon HM; Tirabosco R; Natali C; Zanatta L; Sciot R; Mertens F; Athanasou N; Alberghini M; Szuhai K; Hogendoorn PC; Dei Tos AP
    Virchows Arch; 2012 Nov; 461(5):561-70. PubMed ID: 23001328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of sarcomas occurring in bone and joint: A SEER based study.
    Zhou H; He S; Zhang D; Wang J; Yang X; Jiao J; Xu W; Yang J; Xiao J
    Medicine (Baltimore); 2023 Oct; 102(43):e34231. PubMed ID: 37904412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnoses, treatment, and oncologic outcomes in patients with calcaneal malignances: Case series, systematic literature review, and pooled cohort analysis.
    Newman ET; van Rein EAJ; Theyskens N; Ferrone ML; Ready JE; Raskin KA; Lozano Calderon SA
    J Surg Oncol; 2020 Dec; 122(8):1731-1746. PubMed ID: 32974945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.